Claims
- 1. A method of producing biologically active α-2b-interferon in a duckweed plant culture or a duckweed nodule culture, comprising the steps of:(a) culturing within a duckweed culture medium a duckweed plant culture or a duckweed nodule culture, wherein said duckweed plant culture or said duckweed nodule culture is stably transformed to express said biologically active α-2b-interferon, and wherein said biologically active α-2b-interferon is expressed from a nucleotide sequence comprising a coding sequence for the polypeptide and an operably linked coding sequence for a signal peptide that directs secretion of the α-2b-interferon into the culture medium; and (b) collecting said biologically active α-2b interferon from the duckweed culture medium.
- 2. The method of claim 1, wherein said biologically active α-2b-interferon is secreted into the duckweed culture medium.
- 3. The method of claim 1, wherein said nucleotide sequence has at least one at tribute selected from the group consisting of:(a) duckweed-preferred codons in the coding sequence for said α-2b-interferon; (b) duckweed-preferred codons in the coding sequence for said signal peptide; (c) a translation initiation codon that is flanked by a plant-preferred translation initiation context nucleotide sequence, wherein said plant-preferred translation initiation context nucleotide sequence consists of the nucleotide sequence “ACC” or “ACA”, wherein said context is positioned immediately adjacent to of the 5′ end of the translation initiation codon; and (d) an operably linked nucleotide sequence comprising a plant intron that is inserted upstream of the coding sequence.
- 4. The method according to claim 3, wherein said duckweed-preferred codons are Lemna gibba-preferred codons or Lemna minor-preferred codons.
- 5. The method according to claim 4, wherein at least one coding sequence selected from the coding sequence for said polypeptide and the coding sequence for said signal peptide comprises between 70-100% Lemna gibba-preferred codons or Lemna minor-preferred codons.
- 6. The method according to claim 3, wherein said operably linked nucleotide sequence comprising said plant intron is the sequence set forth in SEQ ID NO:1.
- 7. A method of producing biologically active α-2b-interferon, comprising the steps of:(a) culturing a duckweed plant culture or a duckweed nodule culture, wherein said duckweed plant culture or said duckweed nodule culture is stably transformed to express said biologically active α-2b-interferon, and wherein said biologically active α-2b-interferon is encoded by a nucleotide sequence that has been modified for enhanced expression in duckweed, and (b) collecting said biologically active α-2b-interferon from said duckweed plant culture or said duckweed nodule culture.
- 8. The method of claim 7, wherein said nucleotide sequence that has been modified for enhanced expression in duckweed has at least one attribute selected from the group consisting of:(a) duckweed-preferred codons in the coding sequence for said biologically active α-2b-interferon; (b) a translation initiation codon that is flanked by a plant-preferred translation initiation context nucleotide sequence, wherein said plant-preferred translation initiation context nucleotide sequence consists of the nucleotide sequence “ACC” or “ACA”, wherein said context is positioned immediately adjacent to the 5′ end of the translation initiation codon; and (c) an operably linked nucleotide sequence comprising a plant intron that is inserted upstream of the coding sequence.
- 9. The method according to claim 8, wherein said duckweed-preferred codons are Lemna gibba-preferred codons or Lemna minor-preferred codons.
- 10. The method according to claim 9, wherein the coding sequence comprises betwee 70% and 100% Lemna gibba-preferred codons or Lemna minor-preferred codons.
- 11. The method according to claim 8, wherein said operably linked nucleotide sequence comprising said plant intron is the sequence set forth in SEQ ID NO:1.
- 12. The method according to claim 1, wherein said α-2b-interferon is a human α-2b-interferon.
- 13. The method according to claim 12, wherein said human α-2b-interferon has an amino acid sequence selected from the group consisting of the amino acid sequence set forth in SEQ ID NO:4 and the amino acid sequence set forth in SEQ ID NO:5.
- 14. The method according to claim 1, wherein the biologically active α-2b-interferon variant having at least 80% sequence identity with an amino acid sequence selected from the group consisting of the amino acid sequence set forth in SEQ ID NO:4 and the amino acid sequence set forth in SEQ ID NO:5.
- 15. The method according to claim 1, wherein said signal peptide is selected from the group consisting of:(a) the human α-2b-interferon signal peptide, (b) the Arabidopsis thaliana chitinase signal peptide; (c) the rice α-amylase signal peptide; (d) the modified rice α-amylase peptide; (e) a duckweed signal peptide; and (f) a signal peptide native to the biologically active recombinant polypeptide.
- 16. The method according to claim 15, wherein the signal peptide is the rice α-amylase signal peptide having the sequence set forth in SEQ ID NO:3.
- 17. The stably transformed duckweed plant culture or duckweed nodule culture according claim 1.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application Ser. No. 60/221,705, filed Jul. 31, 2000, and U.S. Provisional Application Ser. No. 60/293,330, filed May 23, 2001; each of which is hereby incorporated in its entirety by reference herein.
US Referenced Citations (9)
Foreign Referenced Citations (6)
Number |
Date |
Country |
0 141 484 |
May 1985 |
EP |
WO 9421796 |
Sep 1994 |
WO |
WO 9836085 |
Aug 1998 |
WO |
WO 9907210 |
Feb 1999 |
WO |
WO 9919497 |
Apr 1999 |
WO |
WO 9947678 |
Sep 1999 |
WO |
Non-Patent Literature Citations (1)
Entry |
Murray, E. E. et al., “Codon Usage Plant Genes,” Nucleic Acids Research, Jan. 25, 1989, pp. 477-498, vol. 17, No. 2. |
Provisional Applications (2)
|
Number |
Date |
Country |
|
60/221705 |
Jul 2000 |
US |
|
60/293330 |
May 2001 |
US |